gonna pull a trick, page-20

My point is they told all there shareholders the exact same story last year, as this ,knocking 20% off the share price again.My point is you can have a great product and ordinary management ,the product will die on the vine.This company seems to think they will just walk in and takeover the market.I dont think it is that easy.Heartmate 2 has been trying for fda approval without a result and heartmate 3 has been scraped.